Free Trial
ASX:CSL

CSL (CSL) Stock Price, News & Analysis

CSL logo

About CSL Stock (ASX:CSL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
869,289 shs
Average Volume
N/A
Market Capitalization
A$77.43 billion
P/E Ratio
28.02
Dividend Yield
1.56%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CSL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter.

CSL Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

CSL Stock Analysis - Frequently Asked Questions

CSL Limited (ASX:CSL) posted its quarterly earnings results on Wednesday, August, 14th. The company reported $4.24 earnings per share for the quarter, beating analysts' consensus estimates of $4.22 by $0.01. CSL had a net margin of 18.41% and a trailing twelve-month return on equity of 15.37%.

Based on aggregate information from My MarketBeat watchlists, some other companies that CSL investors own include Cochlear (COH), Mineral Resources (MIN), ResMed (RMD), Magellan Financial Group (MFG), NIB (NHF), Accent Group (AX1) and Corporate Travel Management (CTD).

Company Calendar

Last Earnings
8/14/2019
Ex-Dividend for 4/8 Dividend
3/09/2025
Record date for 4/8 Dividend
4/08/2025
Dividend Payable
4/08/2025
Today
7/04/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
Rubber And Plastic Products
Current Symbol
ASX:CSL
CIK
N/A
Fax
N/A
Employees
12,500
Year Founded
N/A

Profitability

Trailing P/E Ratio
28.02
Forward P/E Ratio
N/A
P/E Growth
1.29
Net Income
A$2.64 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$14.80 billion
Price / Cash Flow
207.70
Book Value
A$42.52 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$77.43 billion
Optionable
Not Optionable
Beta
0.32
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (ASX:CSL) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners